Augusta Health Center for Cancer and Blood Disorders
Fishersville, Virginia, United States
Cancer treatment center in Fishersville, Virginia
Augusta Health Cancer Center, 78 Medical Center Dr, Fishersville, VA 22939
About Augusta Health Center for Cancer and Blood Disorders
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
18
Alliance for Clinical Trials in Oncology
6
NRG Oncology
4
Radiation Therapy Oncology Group
3
SWOG Cancer Research Network
3
ECOG-ACRIN Cancer Research Group
2
Alliance Foundation Trials, LLC.
1
Canadian Cancer Trials Group
1
NSABP Foundation Inc
1
National Heart, Lung, and Blood Institute (NHLBI)
1
Pfizer
1
Clinical Trials at Augusta Health Center for Cancer and Blood Disorders
During the past decade, Augusta Health Center for Cancer and Blood Disorders conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 10 clinical trials were completed, i.e. on
average, 34.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 10 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
2009-09-01
2025-10-01
Active, not recruiting
1,538
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
2011-01-06
Active, not recruiting
3,270
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
2011-05-01
Active, not recruiting
2,354
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
2011-07-01
2031-07-01
Active, not recruiting
2,592
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
2013-08-27
2023-12-31
Active, not recruiting
349
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
2013-08-01
2028-08-01
Active, not recruiting
1,636
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Augusta Health Center for Cancer and Blood Disorders" #1 sponsor was "National Cancer Institute (NCI)" with 18 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials
sponsored, "NRG Oncology" with 4 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored and "SWOG Cancer Research Network"
with 3 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Augusta Health Center for Cancer and Blood Disorders"
#1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Augusta Health Center for Cancer and Blood Disorders
According to Clinical.Site data, the most researched conditions in "Augusta Health Center for Cancer and Blood Disorders" are
"Breast Cancer" (3 trials), "Invasive Breast Carcinoma" (3 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (3 trials), "Recurrent Breast Carcinoma" (3 trials) and "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "Augusta Health Center for Cancer and Blood Disorders" in a lesser frequency.
Clinical Trials Intervention Types at Augusta Health Center for Cancer and Blood Disorders
Most popular intervention types in "Augusta Health Center for Cancer and Blood Disorders" are "Other" (31 trials), "Drug" (27 trials), "Biological" (13 trials), "Procedure" (13 trials) and "Radiation" (13 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (13 trials), "Biospecimen Collection" (10 trials), "Laboratory Biomarker Analysis" (10 trials), "Questionnaire Administration" (10 trials) and "Computed Tomography" (8 trials). Other intervention names were less common.
Clinical Trials Genders at Augusta Health Center for Cancer and Blood Disorders
The vast majority of trials in "Augusta Health Center for Cancer and Blood Disorders" are
30 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Augusta Health Center for Cancer and Blood Disorders
Currently, there are NaN active trials in "Augusta Health Center for Cancer and Blood Disorders".
undefined are not yet recruiting,
15 are recruiting,
22 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Augusta Health Center for Cancer and Blood Disorders,
1 suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Augusta Health Center for Cancer and Blood Disorders, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 29 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".